Abstract:The expanding gene‐editing toolbox has driven a biomedical revolution. These molecular tools tremendously contribute to the progression of fundamental research, such as epigenetics, drug development, disease modeling, and disease diagnosis. Furthermore, therapeutic gene editing offers a profound opportunity to improve the current treatment of human diseases. The expanding genome editing toolbox has revolutionized life science research ranging from the bench to the bedside. These "molecular scissors" have offered us unprecedented abilities to manipulate nucleic acid sequences precisely in living cells from diverse species. Continued advances in genome editing exponentially broaden our knowledge of human genetics, epigenetics, molecular biology, and pathology. Currently, gene editing‐mediated therapies have led to impressive responses in patients with hematological diseases, including sickle cell disease and thalassemia. With the discovery of more efficient, precise and sophisticated gene‐editing tools, more therapeutic gene‐editing approaches will enter the clinic to treat various diseases, such as acquired immunodeficiency sydrome (AIDS), hematologic malignancies, and even severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. These initial successes have spurred the further innovation and development of gene‐editing technology. In this review, we will introduce the architecture and mechanism of the current gene‐editing tools, including clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR‐associated nuclease‐based tools and other protein‐based DNA targeting systems, and we summarize the meaningful applications of diverse technologies in preclinical studies, focusing on the establishment of disease models and diagnostic techniques. Finally, we provide a comprehensive overview of clinical information using gene‐editing therapeutics for treating various human diseases and emphasize the opportunities and challenges.

Molecular mechanisms, off‐target activities, and clinical potentials of genome editing systems

[Applications of ZFN, TALEN and CRISPR/Cas9 Techniques in Disease Modeling and Gene Therapy].

Off-target Genome Editing: A New Discipline of Gene Science and a New Class of Medicine.

Advances in the Engineering of the Gene Editing Enzymes and the Genomes: Understanding and Handling the Off-Target Effects of CRISPR/Cas9.

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

Applications of Genome Editing Technology in the Targeted Therapy of Human Diseases:Mechanisms,advances and Prospects

Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing

Off-target effects in CRISPR/Cas9 gene editing

Development and application of CRISPR/Cas9 technologies in genomic editing.

Off-target Effects in CRISPR/Cas9-mediated Genome Engineering

Current landscape of gene‐editing technology in biomedicine: Applications, advantages, challenges, and perspectives

CRISPR/Cas9-Mediated Genome Editing in Cancer Therapy

Characterizing off-target effects of genome editors

Epigenome editing by CRISPR/Cas9 in clinical settings: possibilities and challenges.

Chemical and Biological Approaches to Interrogate Off-Target Effects of Genome Editing Tools.

Mitigating the Off-target Effects in CRISPR/Cas9-mediated Genetic Editing with Bioinformatic Technologies

Genome-Editing Technologies: Concept, Pros, and Cons of Various Genome-Editing Techniques and Bioethical Concerns for Clinical Application

The power and the promise of CRISPR/Cas9 genome editing for clinical application with gene therapy

Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing

Off-target Effect of CRISPR/Cas9 and Optimization

Gene Editing and Its Applications in Biomedicine